• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X AORTIC PROSTHETIC HEART VALVE; MECHANICAL HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X AORTIC PROSTHETIC HEART VALVE; MECHANICAL HEART VALVE Back to Search Results
Model Number ONXAE
Device Problem Insufficient Information (3190)
Patient Problem Aortic Regurgitation (1716)
Event Date 12/01/2011
Event Type  No Answer Provided  
Manufacturer Narrative
This is an untreated adverse event.Valve not explanted.It was decided to not treat the pvl.The valve is being left in the patient with the observation during follow-up visits that there is on-going pvl, w/moderate aortic regurgitation grade iii.
 
Event Description
Event occurred in (b)(6).Overall, patient disease etiology was "prosthetic valve dysfunction - calcific" and tissue fragility resulting from re-operation.Patient had a re-do aortic valve replacement using on-x valve, resulted in paravalvular leak (pvl), post-operative-early.Nyha class ii.It was decided to not treat the pvl.The valve is being left in the patient with the observation during follow-up visits that there is on-going pvl, w/ moderate aortic regurgitation grade iii.The aats/sts guidelines defines pvl as valve-related and is reportable.Therefore, this is being reported.This is an expected adverse event and is occurring within expected rate.On (b)(6) 2015, onxlti received a set of data from the sponsor of a (b)(6) post-market study, where-in they wanted on-x to do data analysis on a set of data containing adverse events.The valve on this mdr is one of the ae's.Once analyzed against the entire population in the (b)(6) study (only avr has enough data for proper analysis) and then comparing to the pma.There are no statistically significant differences in these rates and this trail was run at inr of 1.5 to 2.5 versus the pma at 2.0 to 3.0.At lower inr low rates are expected based on our research.So these events while mdr reportable as individual occurrences, they are overall in the range expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X AORTIC PROSTHETIC HEART VALVE
Type of Device
MECHANICAL HEART VALVE
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln, bldg b
austin TX 78752
Manufacturer Contact
walt moeller, director, qa/ra
1300 e. anderson lane, bldg b
austin, TX 78752
5123398000
MDR Report Key5000655
MDR Text Key23422326
Report Number1649833-2015-00015
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,study
Reporter Occupation Not Applicable
Report Date 08/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/27/2016
Device Model NumberONXAE
Device Catalogue NumberONXAE-25
Other Device ID Number00851788001419
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/21/2015
Was Device Evaluated by Manufacturer? No Information
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age37 YR
-
-